Publication date: Oct 05, 2024
Autism spectrum disorder (ASD) poses a significant challenge due to its diverse impact on individuals, emphasizing the need for personalized treatment plans. The financial burden of ASD-related healthcare is substantial, necessitating a comprehensive understanding of its prevalence and evolving trends. This study aims to analyze the prevalence and trends of ASD, treatment patterns, gender differences, and racial-ethnic disparities in the United States from 2017 to 2020, utilizing nationally representative data from the National Survey of Children’s Health (NSCH). The NSCH, a leading annual national survey, provided rich data on child health. A total of 108,142 participants aged 3-17 years were included, with ASD prevalence assessed based on self-reported diagnoses. Between 2017 and 2020, ASD prevalence in children aged 3-17 was 2. 94% (95% confidence interval: 2. 68-3. 18). Significant disparities were observed: older age and male gender correlated with higher prevalence, while family income-to-poverty ratio and insurance coverage influenced prevalence. Racial/ethnic disparities existed, with Hispanics showing the highest prevalence. Treatment trends showed stability overall, but age influenced behavioral and medication interventions. The prevalence remained stable from 2017 to 2020, with variations in age groups and a significant increase among non-Hispanic Whites. This study highlights a higher but stable overall ASD prevalence, with nuanced disparities among different demographic groups. Gender differences persist, emphasizing the need for tailored interventions. Racial-ethnic disparities call for targeted healthcare strategies. The stability in treatment trends underscores the persistent challenge of addressing core ASD symptoms.
Open Access PDF
Concepts | Keywords |
---|---|
Autism | Autism spectrum disorder |
Healthcare | Behavioral intervention |
Hispanics | Childhood neurodevelopment |
Rich | Racial-ethnic disparities |
Treatment intervention |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | Autism Spectrum Disorder |
drug | DRUGBANK | Ethionamide |
drug | DRUGBANK | Coenzyme M |
drug | DRUGBANK | Trestolone |
disease | MESH | depression |
drug | DRUGBANK | Stavudine |
disease | MESH | panic |
disease | MESH | anxiety |
disease | MESH | autism |
disease | MESH | Asperger’s disorder |